Marijuana Does Not Cause Bipolar Disorder, But It Significantly Worsens Symptoms and Increases Risk in Vulnerable Individuals
Cannabis use disorder (CUD) is associated with approximately 2-3 times increased risk of developing bipolar disorder, but the evidence suggests this is not a simple causal relationship—rather, genetic liability to bipolar disorder appears to increase cannabis use, while cannabis then exacerbates the underlying condition. 1, 2, 3
Understanding the Bidirectional Relationship
The relationship between cannabis and bipolar disorder is complex and bidirectional:
Genetic studies reveal that individuals with genetic liability to bipolar disorder are more likely to use cannabis, but genetic liability to cannabis use does not increase bipolar disorder risk 4. This suggests people with bipolar disorder may be predisposed to seek out cannabis, possibly for self-medication.
However, once cannabis use begins, particularly regular or heavy use, it is associated with a 2-3 fold increased risk of developing bipolar disorder 2, 3, 5. A 2023 Danish population study of over 6.6 million individuals found CUD was associated with increased risk for both psychotic bipolar disorder (HR 4.05) and nonpsychotic bipolar disorder (HR 2.96 in men, 2.60 in women) 2.
The risk is particularly elevated for psychotic subtypes of bipolar disorder compared to nonpsychotic forms (relative HR 1.48), suggesting high-THC cannabis may be especially problematic 2.
Critical Clinical Implications
Cannabis use in people with established bipolar disorder consistently worsens symptoms and function 6, 7, 8:
- Cannabis may exacerbate psychiatric disorders in vulnerable individuals and worsen mania symptoms 6, 9
- Multiple guidelines from 2024 emphasize that cannabis use may exacerbate psychiatric disorders, with particular concern for those with bipolar disorder 6
- The 2024 American College of Physicians position paper specifically notes elevated risk for psychotic disorders and depression with early cannabis use 1
Age-Dependent Vulnerability
Adolescent and young adult cannabis use carries the highest risk 1, 7, 5:
- Cannabis use in early youth is associated with neuropsychological decline, elevated risk for psychotic disorders in adulthood, and higher risk for depression 1
- A 2026 cohort study of 463,396 adolescents found past-year cannabis use was associated with doubled risk of incident bipolar disorder (AHR 2.01) 5
- The Substance Abuse and Mental Health Services Administration specifically warns about cannabis use in early youth and its association with multiple psychiatric conditions 1
Dose and Potency Considerations
Higher THC concentrations pose greater psychiatric risks 1:
- Average THC concentration in cannabis nearly doubled from 9% in 2008 to 17% in 2017, with concentrates reaching 70% THC 1
- High doses of THC are specifically associated with psychosis 1
- Regular use of high THC-content products by adolescents and young adults is associated with 2-11 fold increased risk of psychosis 7
Cannabis Use Disorder Risk
People with bipolar disorder who use cannabis are at high risk for developing cannabis use disorder 6:
- 10% of adults with chronic cannabis use develop cannabis use disorder 6
- Among people with past-year cannabis use, about 3 in 10 have CUD, with half having moderate or severe disease 7
- Early onset cannabis use, especially weekly or daily use, strongly predicts future dependence 6
Practical Clinical Guidance
Cannabis use should be avoided in individuals with bipolar disorder or at risk for it 7:
- Cannabis is an important modifiable risk factor that clinicians should actively address
- The current evidence base does not support cannabis use for treating mental health conditions 7
- Clinicians should engage in open, nonjudgmental conversations about cannabis use with patients who have bipolar disorder 6
Important Caveats
The evidence quality varies—while associations are consistent across multiple 2024 guidelines and recent large population studies, establishing definitive causation remains challenging due to potential confounding factors like shared genetic vulnerabilities, self-medication patterns, and other substance use. The bidirectional Mendelian randomization study 4 provides the strongest evidence against simple causation, but does not rule out cannabis as an exacerbating factor in those genetically predisposed.
Bottom line: While marijuana likely does not directly "cause" bipolar disorder in people without underlying vulnerability, it approximately doubles the risk of developing the disorder, dramatically worsens symptoms in those with established disease, and should be strongly discouraged—especially in adolescents, young adults, and anyone with family history of bipolar disorder.